Cameco vs. USA Rare Earth: Which Renewable Energy Stock Is a Better Buy in 2026?

As global demand for reliable power and advanced manufacturing materials surges, investors are evaluating different paths to profit. Is the market leader Cameco Corp (NYSE:CCJ) or the newcomer USA Rare Earth Inc (NASDAQ:USAR) the better pick?

Cameco provides the uranium that fuels nuclear reactors globally, operating as a mature and profitable energy player. In contrast, USA Rare Earth is attempting to build a domestic supply chain for critical magnets and rare earth metals. While they serve different industries, both stocks appeal to those betting on the future of high-tech infrastructure.

The case for Cameco

As a leader among nuclear energy stocks, Cameco produces uranium and fuel services for utilities around the globe. The company serves nuclear utilities in 16 countries, selling products through a mix of long-term contracts and the spot market. This global footprint allows it to capitalize on the increasing interest in carbon-free baseload power.

In FY 2025, revenue reached approximately $2.5 billion, representing about an 11% increase from the prior year. The company reported net income of nearly $425 million during this period, achieving a net margin of about 17%. This reflects a significant upward trend in profitability compared to the 5.5% net margin reported in FY 2024.

As of its December 2025 balance sheet, the debt-to-equity ratio was 0.1x, which compares total debt to the equity held by shareholders. The so-called current ratio, which measures the ability to cover debts due within one year using current assets, was 2.5x. Furthermore, Cameco generated free cash flow of approximately $775 million, which is the cash remaining after paying for operations and capital equipment.

The case for USA Rare Earth

USA Rare Earth is focused on creating an integrated rare earth value chain that spans from mining to magnet manufacturing. The company serves critical sectors including aerospace, defense, and semiconductors through its Less Common Metals subsidiary. A key commercial partnership with Solvay (OTC:SVYSF) aims to supply metals to specialized manufacturers like Arnold Magnetic Technologies.

In FY 2025, the company generated revenue of approximately $1.6 million as it began its early stages of commercial operations. However, it reported a net loss of nearly $298 million, resulting in a massive negative net margin. These figures reflect the high costs associated with scaling its facilities and achieving technical milestones in its development projects.

As of its December 2025 balance sheet, the company maintained a neat debt-to-equity ratio of 0.0x and a current ratio of 10.2x. While the balance sheet appears liquid, USA Rare Earth reported negative free cash flow of approximately $86.3 million. This means the company is currently spending more on its operations and infrastructure than it is generating in cash.

Risk profile comparison

Cameco faces risks primarily related to the cyclical nature of uranium prices and the heavy regulation of the nuclear industry. Changes in government policy or public sentiment toward nuclear power can impact long-term demand for its fuel products. Additionally, the company competes for market share with other large producers such as Energy Fuels Inc (NYSEMKT:UUUU).

USA Rare Earth carries significant execution risk as it scales the Stillwater Facility and the Round Top Project. The company is currently defending a lawsuit from MP Materials Corp (NYSE:MP) alleging misappropriation of technology, which could impact its financial standing. Furthermore, the business depends on securing large-scale financing and navigating the dominance of the Chinese rare earth market.

Valuation comparison

Cameco trades at a higher forward earnings multiple reflecting its established profits, whereas USA Rare Earth has a speculative price-to-sale valuation based on its future growth potential.

Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.

Which stock would I buy in 2026?

Cameco is an essential North American producer of uranium, which is needed for fueling nuclear power plants.

Nuclear energy provides about one-fifth of the U.S. energy supply, and the federal government has an aggressive timeline to quadruple nuclear energy by 2050. New reactor designs are emerging that should make building plants faster and cheaper, helping the nuclear plant market. It's a heavily regulated market for Cameco, but there is an unexpected risk: Donald Trump's fight with Canada could imperil exports of the precious fuel to the U.S. if things escalate.

Still, Cameco's business is seen as fairly stable, growing modestly (low single-digit growth) in the next few years. If you're a believer in long-term nuclear energy growth, it's one of the best plays in the sector. A bonus, Cameco last year purchased about half of Westinghouse, which is the dominant designer and builder of nuclear power plants around the world. Considering other countries, namely South Korea, are planning a boom in Westinghouse-designed plants, that's a plus. Westinghouse typically provides maintenance over the long term for its reactor designs, adding a predictable revenue stream.

USA Rare Earth, meanwhile, is seeking to be the second U.S. provider of rare-earth elements after MP Materials. The rare earth and rare-earth concentrate markets are dominated by China. That creates a risk: Chinese production levels and inventory stockpiling could lead to lower prices and adversely impact USAR's revenue. But that also provides the company's opportunity: national security and energy security increasingly rely on the usage of rare-earth metals to make things like magnets in EVs and wind turbines more efficient, and for classified usage in munitions.

There is likely room for both MP and USAR -- at least Wall Steet thinks so. Analysts project USAR to be fast growing, hitting sales of more than $700 million in fiscal 2027, nearly 10 times projections for 2026 and vastly greater than last year's $1 million and change sales.

Still, rare earths is capital intensive, while Cameco is an essential provider of uranium in a market where nuclear power is expected to boom. For 2026, Cameco is the better bet.

Brendan Coffey has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Cameco and MP Materials. The Motley Fool has a disclosure policy.